Brought to you by:

Cell & Gene Therapy

hurdles hurdles ahead
Biotech

FDA steers CAR-T developers toward randomized superiority trials

Under plans outlined by Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to show superiority over existing treatments.
Nick Paul Taylor Dec 9, 2025 4:33am
DNA strand

Encoded deciphers pivotal path with phase 1/2 gene therapy data

Dec 5, 2025 12:45pm
dynamic arrows moving up

Capricor sets up 2nd DMD approval attempt with ph. 3 win

Dec 3, 2025 11:11am
Completing steps towards success checkmark on cubes symbolizing progress

Muvon flexes muscle cell data to challenge incontinence implants

Dec 3, 2025 8:19am
psych neuro brain

Imvax takes brain cancer therapy to FDA despite missing primary

Dec 2, 2025 8:00am
Graphic of two hands shaking under a red and purple light

Regeneron inks $150M pact with gene writer Tessera

Dec 1, 2025 11:12am